Diabetes Screening for Pregnancy: Expert Recommendations
Endocrine Society and American Diabetes Association Release Landmark Clinical Practice Guideline for Gestational diabetes Mellitus
Table of Contents
New Guideline Offers Evidence-Based Recommendations for Diagnosis, Treatment, and Management
The Endocrine Society, in collaboration with the American Diabetes Association and several other leading professional organizations, has released a thorough Clinical Practice Guideline for the diagnosis, treatment, and management of gestational diabetes mellitus (GDM). This pivotal guideline aims to equip endocrinologists and other healthcare professionals with the most current,evidence-based recommendations to improve outcomes for both mothers and their infants.
The guideline was developed by a multidisciplinary panel of esteemed experts, meticulously following a rigorous methodology to ensure the highest quality of recommendations. The collaborative effort underscores the shared commitment of these organizations to advancing the care of individuals with GDM.
key Organizations Driving Advancements in GDM Care
The development of this crucial guideline was a testament to the power of collaboration,with co-sponsorship from a distinguished group of professional bodies:
American Diabetes Association
American College of Obstetricians and Gynecologists
Society for Maternal-Fetal Medicine
The International Association of the Diabetes and Pregnancy Study Groups
European Association for the Study of Diabetes
Association of Diabetes Care and Education Specialists
American Pharmacists Association
This broad coalition of expertise ensures that the guideline addresses the multifaceted nature of GDM care from various clinical perspectives.
Expert panel Driving Evidence-Based Recommendations
The guideline writing panels are the backbone of the Endocrine Society’s Clinical Practice Guideline Program. These panels are composed of topic-related experts who conduct thorough evidence-based reviews of the literature. This rigorous process ensures that the recommendations provided are grounded in the latest scientific evidence.
The Endocrine Society and ESE (European Society of Endocrinology) maintain a strict policy of not soliciting or accepting corporate support for their guidelines, ensuring their independence and objectivity. All Clinical Practice Guidelines are supported entirely by Society funds, reinforcing their commitment to unbiased, evidence-based guidance.
The distinguished panel members contributing to this GDM guideline include:
Chair: Mark Molitch of Northwestern University Feinberg School of Medicine in Chicago, Ill.
Co-Chair: Boyd E. Metzger of northwestern University Feinberg School of medicine in Chicago, Ill.
Members:
J. Michael Gonzalez-Campoy of the Endocrine Society in Washington, D.C.
Linda A. Barbour of the University of Colorado School of Medicine and Anschutz Medical Campus in Aurora, Colo.
Florence M. Brown of Joslin Diabetes Center in Boston, Mass.
Patrick M. Catalano of Massachusetts General Hospital and harvard Medical School in Boston, Mass.
Rosa Corcoy of Hospital de la Santa Creu i Sant Pau in Barcelona, Spain, CIBER-BBN in Madrid, spain, and Universitat Autònoma de Barcelona in Barcelona, Spain
Gian Carlo Di Renzo of PREIS International School and Meyer Children’s University Hospital in Florence, Italy
Nancy Drobycki of the University of Texas Southwestern Medical Center of Dallas in Dallas, Texas
Alexandra Kautzky-Willer of the Medical University of vienna in Vienna, Austria
M. Hassan Murad of the Mayo Clinic Evidence-Based Practice Center in Rochester, Minn.
Melanie Stephenson-Gray of national Health Service in Cardiff,United Kingdom
Adam G. Tabák of Semmelweis University of Medicine in Budapest, Hungary, and the University College London in London, United Kingdom
Emily Weatherup of the University of Michigan in Ann Arbor, mich.
Chloe Zera of the Beth Israel Deaconess Medical Center in Boston, Mass.
Naykky Singh-ospina of the University of Florida in Gainesville, Fla.
About the Endocrine Society
Endocrinologists play a critical role in addressing some of the most pressing health challenges of our time, including diabetes, obesity, infertility, bone health, and hormone-related cancers.The Endocrine Society stands as the world’s oldest and largest organization dedicated to hormone research and the care of individuals with hormone-related conditions.
With a global membership exceeding 18,000 scientists, physicians, educators, nurses, and students across 122 countries, the Endocrine Society is at the forefront of advancing endocrinology. For more facts about the Society and the field of endocrinology, visit www.endocrine.org. Follow the Endocrine Society on X (formerly twitter) at [@TheEndoSociety](https://twitter.com/